Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Creative Medical, Diurnal, Innovent, Lantheus, Merck, Moderna, Neurosense, Veralox.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Clearmind Biomedical, Medtronic, Organogenesis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerie, Amydis, Axcella, Boehringer, Chipscreen, Cytokinetics, Editas, Eli Lilly, Ideaya, Istari, Exicure, Lysogene, Neuren, Obseva, Organogenesis, RDIF, Receptor Life Sciences, Roche.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inari Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Bayer, Glaxosmithkline, Medicure, Merus, Moderna, Neoleukin.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiowise, Locate Bio, Siemens Healthineers.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apollomics, Bluerock, Gemini, Glycomimetics, Inversago, Praxis Precision, Union, Visen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Northstar Medical Radioisotopes, Spectrum Solutions, Ultromics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amolyt, Astellas, Astrazeneca, Everest, Inventiva, Moderna, RDIF, Redhill, Stealth.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Arcturus, Astrazeneca, Biocure Technology, Capricor, Celltrion, Hutchison China Meditech, Pharos Vaccine, Tracon.